Hydroquinone: The Gold Standard for Dark Spots, and Why It Needs a Provider
If you read our vitamin C post, you saw hydroquinone show up as the benchmark that other brightening ingredients get measured against. There's a reason for that. For decades, hydroquinone has been one of the most effective tools we have for melasma and stubborn dark spots. It's also one of the most misunderstood, and it's no longer something you can pick up at the drugstore. Here's what the research actually says.
How hydroquinone works
Your skin makes pigment (melanin) with the help of an enzyme called tyrosinase. Hydroquinone blocks that enzyme, which slows down pigment production. Over time, existing dark patches fade as your skin naturally turns over.
Why you can't buy it over the counter anymore
Until 2020, you could buy 1–2% hydroquinone creams off the shelf. That changed with the CARES Act, which overhauled how the FDA regulates over-the-counter drugs. Hydroquinone was moved out of the over-the-counter category, and the FDA has since sent warning letters to companies still selling it without a prescription. (Practical Dermatology; MDedge)
This was a regulatory change, not proof that hydroquinone causes cancer, which is a common myth. The bigger concern dermatologists raise now is that people turn to unregulated creams bought online or overseas, which can contain much higher hydroquinone levels and sometimes even mercury. Please don't do that.
What the studies show
The "triple cream" for melasma. In two large randomized trials with 641 patients, a cream combining 4% hydroquinone with tretinoin and a mild steroid was compared with two-ingredient versions. After 8 weeks, about 26% of patients using the triple cream had complete clearing, compared with roughly 5% across the other groups. (Taylor et al., 2003)
Hydroquinone vs. vitamin C. In the split-face study from our vitamin C post, patients rated hydroquinone higher for melasma (93% good or excellent vs. about 63% for vitamin C). But about 69% had side effects from hydroquinone, compared with about 6% from vitamin C. (Espinal-Perez et al., 2004) Hydroquinone is powerful, and power comes with trade-offs.
The safety piece: ochronosis
The most talked-about risk is exogenous ochronosis, a blue-gray or blue-black darkening of the skin. It's rare. One report found only around 22 documented US cases over more than 50 years. (Dermatology Online Journal)
Still, it matters. A systematic review of 126 reported cases found it was most often linked to hydroquinone strengths above 4% (or unknown strengths) and treatment courses longer than 3 months. Cases were reported most often in deeper skin tones. (Int J Dermatol, 2022) This is exactly why hydroquinone should be used in planned courses with breaks, under a provider's guidance, and never as an "apply forever" product.
More common side effects are redness, dryness, and irritation, especially early on.
How hydroquinone is used safely
Prescription only, with a plan from a licensed prescriber.
Used in time-limited courses with planned breaks, often alternating with gentler ingredients.
Daily sunscreen is non-negotiable. Sun undoes pigment treatment faster than any cream can fix it.
Apply only to the areas being treated, and patch test first.
Tell your provider if you're pregnant, trying to conceive, or breastfeeding.
Never use unregulated imported lightening creams.
Myth vs. Fact
Myth: Hydroquinone was pulled because it causes cancer. Fact: It left store shelves because of a change in FDA over-the-counter rules. Dermatologists note there's no reported cancer data in humans from topical use.
Myth: If 4% works, 8% works twice as well. Fact: Higher strengths and longer courses are linked to a higher risk of ochronosis. More isn't better.
What newer research shows
Hydroquinone still holds its own in recent research, and melasma care is moving toward combinations:
A 2025 analysis compared 15 melasma treatments across 14 randomized trials published from 2022 to 2025. 4% hydroquinone performed about as well as the "triple cream," while some combinations, like tranexamic acid paired with hydroquinone, ranked higher. (Leung et al., 2025)
In a 2023 randomized trial of 48 women, nightly 4% hydroquinone and tranexamic acid injections every two weeks both cut melasma severity scores by about 60% over six months, with no significant difference between them. (Pazyar et al., 2023)
The catch: most of these trials are small, and melasma tends to come back, which is why a long-term maintenance plan matters as much as the initial treatment.
The honest bottom line
Hydroquinone is still one of the most effective treatments for melasma and dark spots, especially in combination therapy. It's also a true medication that deserves a plan, a timeline, and supervision. Used well, it can be life-changing. Used carelessly, it can backfire.
Struggling with melasma or dark spots that won't budge? Book a consultation with Then & Now Aesthetics and Wellness. We'll look at your skin, talk through every option, from gentle brighteners to prescription treatments, and build a safe plan that works for you.
You, Beautifully Enhanced.
This post is for educational purposes and isn't a substitute for personalized medical advice. Hydroquinone requires a prescription from a licensed provider.
About the Author
Rebecca Guiheen, BSN, RN, is the founder of Then & Now Aesthetics and Wellness in Kansas City. She brings 15 years of ICU nursing experience to her aesthetics practice and is completing her Family Nurse Practitioner (FNP) degree, with a focus on hormonal health and aging gracefully.
References
Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72(1):67–72.
Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43(8):604–607. https://pubmed.ncbi.nlm.nih.gov/15304189/
Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2022;61(6):675–684. https://pubmed.ncbi.nlm.nih.gov/34486734/
Exogenous ochronosis (case report and review). Dermatology Online Journal. https://escholarship.org/uc/item/3b67z1vb
Where is the hydroquinone? Regulatory change hinders access. Practical Dermatology. https://practicaldermatology.com/news/where-is-the-hydroquinone-regulatory-change-hinders-access
Talakoub L. Goodbye, OTC hydroquinone. MDedge Dermatology. https://mdedge.com/content/goodbye-otc-hydroquinone
Leung JH, Leung HWC, Wang SY, Jang YC, Chan ALF. Efficacy and safety of different treatments for melasma: network meta-analysis of updated data. Diseases. 2025;13(10):316. https://www.mdpi.com/2079-9721/13/10/316
Pazyar N, Babazadeh Dezfuly M, Hadibarhaghtalab M, et al. Intradermal tranexamic acid versus topical 4% hydroquinone for melasma: a randomized controlled trial. J Clin Aesthet Dermatol. 2023;16(1):35–40. https://jcadonline.com/tranexamic-acid-topical-melasma/
Comments